Chanda S, Mangipudy R S, Warbritton A, Bucci T J, Mehendale H M
Division of Pharmacology and Toxicology, College of Pharmacy and Health Sciences, Northeast Louisiana University, Monroe 71209-0470.
Hepatology. 1995 Feb;21(2):477-86.
Acetaminophen (APAP) is a widely used analgesic and antipyretic drug that causes massive centrilobular hepatic necrosis at high doses, leading to death. The objectives of this study were to test our working hypothesis that preplaced cell division and hepatic tissue repair by prior thioacetamide (TA) administration provides protection against APAP-induced lethality and to investigate the underlying mechanism. Male Sprague-Dawley rats were treated with a low dose of TA (50 mg/kg, intraperitoneally [i.p.]) before challenge with a 90% lethal dose (1,800 mg/kg, i.p.) of APAP. This protocol resulted in a 100% protection against the lethal effect of APAP. Because TA caused a 23% decrease of hepatic microsomal cytochromes P-450, the possibility that TA protection may be caused by decreased bioactivation of APAP was examined. A 30% decrease in cytochromes P-450 induced by cobalt chloride failed to provide protection against APAP lethality. Time course of serum enzyme elevations (alanine aminotransferase, aspartate aminotransferase, and sorbitol dehydrogenase) indicated that actual infliction of liver injury by APAP peaked between 12 to 24 hours after the administration of APAP, whereas the ultimate outcome of that injury depended on the biological events thereafter. Although liver injury progressed in rats receiving only APAP, it regressed in rats pretreated with TA. Acetaminophen t1/2 was not altered in TA-treated rats, indicating that significant changes in APAP disposition and bioactivation are unlikely. Moreover, hepatic glutathione was decreased to a similar extent regardless of TA pretreatment, suggesting that decreased bioactivation of APAP is unlikely to be the mechanism underlying TA protection. [3H]Thymidine incorporation studies confirmed the expected stimulation of S-phase synthesis, and proliferating cell nuclear antigen studies showed a corresponding stimulation of cell division through accelerated cell cycle progression. Intervention with TA-induced cell division by colchicine antimitosis ended the TA protection in the absence of significant changes in the time course of serum enzyme elevations during the inflictive phase of APAP hepatotoxicity. These studies suggest that hepatocyte division and tissue repair induced by TA facilitate sustained hepatic tissue repair after subsequent APAP-induced liver injury, producing recovery from liver injury and protection against APAP lethality.
对乙酰氨基酚(APAP)是一种广泛使用的止痛和解热药物,高剂量时会导致大规模的小叶中央性肝坏死,进而导致死亡。本研究的目的是检验我们的工作假设,即预先给予硫代乙酰胺(TA)使细胞分裂和肝组织修复提前,可提供针对APAP诱导的致死性的保护作用,并研究其潜在机制。雄性Sprague-Dawley大鼠在接受90%致死剂量(1800mg/kg,腹腔注射[i.p.])的APAP攻击前,先用低剂量的TA(50mg/kg,腹腔注射)进行处理。该方案对APAP的致死作用提供了100%的保护。由于TA导致肝微粒体细胞色素P-450减少了23%,因此研究了TA保护作用可能是由APAP生物活化降低引起的可能性。氯化钴诱导的细胞色素P-450减少30%未能提供针对APAP致死性的保护作用。血清酶(丙氨酸转氨酶、天冬氨酸转氨酶和山梨醇脱氢酶)升高的时间进程表明,APAP造成的肝损伤在给予APAP后12至24小时达到峰值,而该损伤的最终结果取决于此后的生物学事件。虽然仅接受APAP的大鼠肝损伤持续进展,但预先用TA处理的大鼠肝损伤有所消退。TA处理的大鼠中对乙酰氨基酚的t1/2未改变,表明APAP的处置和生物活化不太可能发生显著变化。此外,无论是否进行TA预处理,肝谷胱甘肽均降低到相似程度,这表明APAP生物活化降低不太可能是TA保护作用的潜在机制。[3H]胸腺嘧啶掺入研究证实了预期的S期合成刺激,增殖细胞核抗原研究显示通过加速细胞周期进程相应地刺激了细胞分裂。在APAP肝毒性的致伤阶段,用秋水仙碱抗有丝分裂干预TA诱导的细胞分裂,在血清酶升高的时间进程无显著变化的情况下,终止了TA的保护作用。这些研究表明,TA诱导的肝细胞分裂和组织修复促进了随后APAP诱导的肝损伤后的持续肝组织修复,使肝损伤得以恢复,并提供针对APAP致死性的保护作用。